Janet Woodcock, acting FDA commissioner (AP Images)
February 23, 2021 06:45 AM EST
FDA+

FDA is­sues new rec­om­men­da­tions to take on Covid-19 vari­ants

Michael Mezher

The FDA on Mon­day un­veiled rec­om­men­da­tions for vac­cine, drug and di­ag­nos­tic test de­vel­op­ers to ad­dress the im­pact of Covid-19 vari­ants on the ef­fi­ca­cy and per­for­mance …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times